Decoy Therapeutics, Inc. (DCOY)
0.702
+0.02
(+2.93%)
USD |
NASDAQ |
Feb 26, 16:00
0.6966
-0.01
(-0.77%)
After-Hours: 19:07
Decoy Therapeutics Total Assets (Quarterly) : 6.097M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Amgen, Inc. | 90.59B |
| Eli Lilly & Co. | 112.48B |
| ACADIA Pharmaceuticals, Inc. | 1.331B |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 140.92M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.849M |
| Shareholders Equity (Quarterly) | 4.248M |
| Current Ratio | 2.791 |